8049 — Jilin Province Huinan Changlong Bio-pharmacy Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Market Cap
HK$1.18bn
Enterprise Value
HK$443.47m
Revenue
CNY881.16m

Annual balance sheet for Jilin Province Huinan Changlong Bio-pharmacy Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	243	262	1,032	656	539
Net Total Accounts Receivable
Net Total Receivables	469	503	585	440	455
Total Inventory
Total Other Current Assets
Total Current Assets	808	890	1,767	1,201	1,099
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	347	398	360	330	313
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,805	2,072	2,373	2,319	2,531
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	415	572	715	725	861
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	459	619	761	838	901
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	1,345	1,454	1,612	1,480	1,630
Total Liabilities & Shareholders' Equity	1,805	2,072	2,373	2,319	2,531
Total Common Shares Outstanding